EUVIMEDOpdag EUVIMED
Crossref

Cross‐reactivity of hantavirus antibodies after immunization with PUUV antigens

Layaly Shkair, Diksha Sharma, Shaimaa Hamza, Ekaterina Garanina, Venara Shakirova, Ilsiyar Khaertynova, Maria Markelova, Vera Pavelkina, Albert Rizvanov, Svetlana Khaiboullina, Manoj Baranwal, Ekaterina Martynova iD

Biotechnology and Applied Biochemistry · 2024-10 · 71 (5) · 1139-1153

DOI: 10.1002/bab.2604 ↗

At a glance

Journal article in Biotechnology and Applied Biochemistry, published online on 2024-05-23. Written by Layaly Shkair and 11 co-authors. Institution: Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia. Major MEDLINE topics: Cross Reactions, Antigens, Viral, Antibodies, Viral, Puumala virus. Cited 2 times so far (Crossref); 73 references. Funded by: RSF-DST, DST/INT/RUS/RSF/P-51/2021.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Nephropathia epidemica (NE), caused by Puumala (PUUV) orthohantavirus, is endemic in the Republic of Tatarstan (RT). There are limited options for NE prevention in RT. Currently, available vaccines are made using Haantan (HNTV) orthohantavirus antigens. In this study, the efficacy of microvesicles (MVs) loaded with PUUV antigens to induce the humoral immune response in small mammals was analyzed. Additionally, the cross‐reactivity of serum from immunized small mammals and NE patients with HNTV, Dobrava, and Andes orthohantaviruses was investigated using nucleocapsid (N) protein peptide libraries. Finally, the selected peptides were analyzed for allergenicity, their ability to induce an autoimmune response, and their interaction with Class II HLA. Several N protein peptides were found to be cross‐reactive with serum from MVs immunized small mammals. These cross‐reactive epitopes were located in oligomerization perinuclear targeting and Daxx‐interacting domains. Most cross‐reactive peptides lack allergenic and autoimmune reactivity. Molecular docking revealed two cross‐reacting peptides, N6 and N19, to have good binding with three Class II HLA alleles. These peptides could be candidates for developing vaccines and therapeutics for NE.

Subjects

MeSH terms (MEDLINE)

Cross ReactionsAntigens, ViralAntibodies, ViralPuumala virusAnimalsHumansImmunizationMolecular Docking SimulationOrthohantavirus

Author keywords

PUUVantibodieshantavirus

Substances

Antigens, ViralAntibodies, Viral

Authors and institutions

  • Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
  • Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala, India.
  • Department of Infectious Diseases, Kazan State Medical Academy, Kazan, Russia.
  • Infectious Diseases Department, National Research Ogarev Mordovia State University, Saransk, Russia.

ORCID profiles: Ekaterina Martynova

Funding

  • RSF-DST
  • DST/INT/RUS/RSF/P-51/2021

Cite

APA

Shkair, L., Sharma, D., Hamza, S., Garanina, E., Shakirova, V., Khaertynova, I., Markelova, M., Pavelkina, V., Rizvanov, A., Khaiboullina, S., Baranwal, M., & Martynova, E. (2024). Cross‐reactivity of hantavirus antibodies after immunization with PUUV antigens. Biotechnology and Applied Biochemistry, 71(5), 1139-1153. https://doi.org/10.1002/bab.2604

Vancouver

Shkair L, Sharma D, Hamza S, Garanina E, Shakirova V, Khaertynova I, et al. Cross‐reactivity of hantavirus antibodies after immunization with PUUV antigens. Biotechnology and Applied Biochemistry. 2024;71(5):1139-1153. doi:10.1002/bab.2604

BibTeX
@article{Shkair2024,
  author = {Shkair, Layaly and Sharma, Diksha and Hamza, Shaimaa and Garanina, Ekaterina and Shakirova, Venara and Khaertynova, Ilsiyar and Markelova, Maria and Pavelkina, Vera and Rizvanov, Albert and Khaiboullina, Svetlana and Baranwal, Manoj and Martynova, Ekaterina},
  title = {Cross‐reactivity of hantavirus antibodies after immunization with PUUV antigens},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2024},
  volume = {71},
  number = {5},
  pages = {1139--1153},
  doi = {10.1002/bab.2604}
}
Start for free →